Drugs / Filgrastim (G-CSF)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03263936 Background | Jul 2017 → Jul 2020 | acute myeloid leukemia | Therapeutic Advances in Childhood Leukemia Consortium | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Filgrastim (G-CSF) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03263936 ↗ |
| Route | Intravenous | “IV or SQ” NCT03263936 ↗ |
| Route | Subcutaneous | “IV or SQ” NCT03263936 ↗ |